STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[SCHEDULE 13G] Caris Life Sciences, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



TSSP Sub-Fund HoldCo, LLC
Signature:/s/ Joshua Peck
Name/Title:Joshua Peck, Vice President
Date:07/28/2025
Alan Waxman
Signature:/s/ Joshua Peck
Name/Title:Joshua Peck, on behalf of Alan Waxman (*)
Date:07/28/2025

Comments accompanying signature: Joshua Peck is signing on behalf of Mr. Waxman pursuant to an authorization and designation letter dated December 31, 2024, filed herewith.
Exhibit Information

Exhibit 1 - Agreement of Joint Filing Exhibit 2 - Authorization and Designation Letter, dated December 31, 2024, by Alan Waxman (filed herewith)

Caris Life Sciences, Inc.

NASDAQ:CAI

CAI Rankings

CAI Latest News

CAI Latest SEC Filings

CAI Stock Data

7.20B
116.29M
49.02%
46.08%
0.69%
Biotechnology
Services-medical Laboratories
Link
United States
IRVING